Open Source in Biotech

Businessworld has an article in the current issue with the same title. Talking about BioForge, it takes The Patents & Copyright Debate forward in various application domains.

The basic premise of the story is that

Cambia has challenged the patents web of the biotech giants by offering its gene transfer technology free.

. Earlier we have seen the clarion call to OpenAccess for knowledge being put forward and very systematically implemented by the BOAI and PLOS. A BioForge is a better way to allow

scientists in diverse locations to work together with those who are positioned to apply their research. Many great ideas and inventions are never practically applied, commercialized or used by those who need them, because of the lack of connection with the people who have the testing facilities, farm fields, appropriate germplasm etc. to try it out locally; or the people who have the local expertise to recognize needs that the technology can fill.

Check out the whitepapers at this site.

A collaborative platform motivated through peer driven acceptance of ideas would lead to a more transparent system with scientific accountability. Not too long ago, dipankar-da talked about the fact that Linux or such like initiatives would become the brand-name through which Open Sourcing or Open Access would be seen. And success of Linux has certainly made it clear to a lot of other projects that the model is scalable and easily replicable.